Verrica Total Current Assets from 2010 to 2024

VRCA Stock  USD 7.26  0.50  7.40%   
Verrica Pharmaceuticals' Total Current Assets are increasing over the years with slightly volatile fluctuation. Total Current Assets are expected to dwindle to about 57.9 M. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2016-12-31
Previous Quarter
91.7 M
Current Value
77.5 M
Quarterly Volatility
26.8 M
 
Covid
Check Verrica Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Verrica main balance sheet or income statement drivers, such as Net Interest Income of 605.9 K, Interest Expense of 4.2 M or Selling General Administrative of 17.5 M, as well as many exotic indicators such as Price To Sales Ratio of 68.01, Dividend Yield of 0.0 or PTB Ratio of 17.63. Verrica financial statements analysis is a perfect complement when working with Verrica Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Verrica Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Verrica Pharmaceuticals Technical models . Check out the analysis of Verrica Pharmaceuticals Correlation against competitors.
For information on how to trade Verrica Stock refer to our How to Trade Verrica Stock guide.

Latest Verrica Pharmaceuticals' Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of Verrica Pharmaceuticals over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Verrica Pharmaceuticals' Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Verrica Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
       Timeline  

Verrica Total Current Assets Regression Statistics

Arithmetic Mean32,132,968
Geometric Mean6,123,496
Coefficient Of Variation110.30
Mean Deviation32,556,366
Median9,083,000
Standard Deviation35,441,831
Sample Variance1256.1T
Range89.3M
R-Value0.79
Mean Square Error497.8T
R-Squared0.63
Significance0.0004
Slope6,300,356
Total Sum of Squares17585.7T

Verrica Total Current Assets History

202457.9 M
202377.5 M
202239.1 M
202174.3 M
202065.5 M
201965 M
201889.8 M

About Verrica Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Verrica Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Verrica Pharmaceuticals investors use historical funamental indicators, such as Verrica Pharmaceuticals's Total Current Assets, to determine how well the company is positioned to perform in the future. Although Verrica Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Verrica Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Verrica Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Verrica Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Verrica Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Current Assets77.5 M57.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Verrica Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Verrica Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Verrica Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Verrica Pharmaceuticals Stock:
Check out the analysis of Verrica Pharmaceuticals Correlation against competitors.
For information on how to trade Verrica Stock refer to our How to Trade Verrica Stock guide.
Note that the Verrica Pharmaceuticals information on this page should be used as a complementary analysis to other Verrica Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Verrica Stock analysis

When running Verrica Pharmaceuticals' price analysis, check to measure Verrica Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verrica Pharmaceuticals is operating at the current time. Most of Verrica Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Verrica Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verrica Pharmaceuticals' price. Additionally, you may evaluate how the addition of Verrica Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
CEOs Directory
Screen CEOs from public companies around the world
Money Managers
Screen money managers from public funds and ETFs managed around the world
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Is Verrica Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verrica Pharmaceuticals. If investors know Verrica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verrica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.48)
Revenue Per Share
0.113
Quarterly Revenue Growth
28.235
Return On Assets
(0.63)
Return On Equity
(2.24)
The market value of Verrica Pharmaceuticals is measured differently than its book value, which is the value of Verrica that is recorded on the company's balance sheet. Investors also form their own opinion of Verrica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Verrica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verrica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Verrica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verrica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Verrica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verrica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.